Reminyl, Amaryl Name Confusion Concerns ISMP
This article was originally published in The Pink Sheet Daily
Executive Summary
Confusion between the antidiabetic Amaryl and the Alzheimer’s medication Reminyl has resulted in medication errors, the Institute for Safe Medication Practices says. ISMP is working with FDA, Aventis and Janssen to develop a solution.